🙏 for the invaluable support in #BiosimilarsLatAm - #Europe2024 , online forum designed to foster the growth of #biosimilars in LatAm, connects industry leaders, experts, and regulators, providing insights into regional opportunities, regulatory trends, and partnership models.

#BiosimilarsLatAm - #Colombia2024 Pablo Quiroga Adame shed light on the importance of communication and governance in the regulatory ecosystem. He emphasized that dialogue between regulators and the regulated is crucial for progress and strength.
#COFEPRIS
#RegulatoryStrategy

#BiosimilarsLatAm - #Colombia2024 Monique Mantovani emphasized the importance of dialogue with local regulatory agencies like #ANVISA , highlighting how such discussions can streamline the #biosimilar registration process and pave the way for local production.
#LocalProduction

#BiosimilarsLatAm - #Colombia2024
Carlos highlighted the achievement of institutions in educating stakeholders about the complexities of #biosimilars , persuading them to invest in initiatives that benefit public health. 🌟💼
INNOS
#HealthcareAdvocacy #PublicHealth

#BiosimilarsLatAm - #Colombia2024 , Ximena Bonilla emphasized the critical importance of local development and production of health technologies, particularly highlighted by the challenges Colombia faced during the pandemic. 🌟
IDCBIS
#biosimilars

#BiosimilarsLatAm - #Colombia2024
Andrea Bedoya stressed the importance of developing local infrastructure, training local talent, and engaging the diaspora abroad to meet the #biosimilar needs of Colombian patients and harness economic benefits. INCANCEROLOGÍA VEDASCII

#BiosimilarsLatAm - #Colombia2024 , claudia vaca moderated the '🇨🇺 Regulatory Expertise for the 🇨🇴 Market: Biologics Case Studies' She emphasized the importance of updating regulatory policies to align with global standards & fostering #collaboration within LatAm. #biosimilars

#BiosimilarsLatAm - #Colombia2024 , Jayadeep Shukla moderated the panel session 'Key Note: Unveiling the Keys to Local Production in LatAm.' He highlighted the importance of learning from neighboring countries and Asia to enhance access to biological medicines in Colombia & LatAm

José Luis Cárdenas at #BiosimilarsLatAm - #Colombia2024 , stressed a multi-criteria approach over price-centricity. It ensures healthcare systems and patients benefit fully from #biosimilars , fostering sustainable supply and better outcomes.

Erik Perez at #BiosimilarsLatAm - #Colombia2024 highlighted the ongoing efforts of CECMED in updating #biosimilar regulations to align with WHO Guidelines & international standards. Exciting advancements ahead for ensuring quality and accessibility in the Colombian market!

🚀 Fernando Carmona at #Biosimilars LatAm - #Colombia2024 , leveraging artificial intelligence & computer modeling for bioreactor platform optimization.
Let's harness the power of technology to drive innovation in biopharmaceuticals!
Cytiva
#Biosimilars #AI #PredictiveAnalytics

🌟 Ramsés Gamboa delivered an insightful session at #BiosimilarsLatAm - #Colombia2024 on fostering a winning culture in #biosimilar projects. Highlighting the challenges of uncertainty and risk, he emphasized the importance of simplifying processes to mitigate these challenges.

🔬 LUZ RIAÑO at #BiosimilarsLatAm - #Colombia2024 shed light on the vital role of ultrafiltration in recombinant human insulin production. Highlighting the growing demand for insulin therapeutics amid rising diabetes prevalence, she emphasized the need to enhance accessibility.

💡 Insights from Joseph Park at #Biosimilars LatAm - #Colombia2024 : Highlighting Brazil's PDPs as a regulatory model to boost local biosimilar manufacturing and enhance healthcare access. 🇧🇷🔬 #Biosimilars #RegulatoryPolicy #HealthcareAccess

🚀 Sergio Torres Pérez's #BiosimilarsLatAm session highlighted vital collaborations driving biosimilar development! Emphasizing @UDIBI's partnership with INC-Colombia, he showcased the significance of local manufacturing for biosimilars. 💡🤝 #HealthcareInnovation #Collaboration

🌟 A heartfelt thank you to all the incredible participants of #BiosimilarsLatAm - #Colombia2024 ! Together, we delved into critical discussions, shared invaluable knowledge, and forged new connections that will drive the #biosimilars industry forward.
#Collaboration

Juan de Villafranca at #BiosimilarsLatAm - #Colombia2024 address delved into the significance of sustainable public policies driving pharmaceutical industry advancement, notably focusing on #biosimilars .

Honored to recognize @UNColombia's Center for Medicines, Information, and Power at #BiosimilarsLatAm - Colombia 2024! Their dedication to public health research and equitable access to medicines is truly commendable. Congratulations on your invaluable contribution! 🏆👏 #UNAL

#RegulatoryUpdates in Colombia at #BiosimilarsLatAm - #Colombia2024 , Clara Sanchez, Advisor at ASCIF highlighted the critical role of societal trust in acquiring health technologies. Join us in fostering trust & advancing healthcare accessibility!
#biosimilars

#BiosimilarsLatAm - #Colombia2024 kicked off with great enthusiasm and engagement. The forum has brought together key stakeholders, industry leaders, and experts to delve into the transformative potential of #biosimilars in shaping the future of medicine.
#HealthcareInnovation